Effects of aristotelia chilensis berry juice on cyclooxygenase 2 expression, NF-κB, NFAT, ERK1/2 and PI3K/Akt activation in colon cancer cells;Efecto de un concentrado del fruto de aristotelia chilensis sobre la expresión de cicloxigenasa 2, NF-k{cyrillic}B, NFAT, ERK1/2 y activación de PI3K/Akt en células de cancer de colon

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas

Volumn 10, Issue 6, 2011, Pages 543-552

  Ojeda, Juan ^a   Jara, Evelyn ^a   Molina, Luis ^a   Parada, Fabiana ^a   Burgos, Rafael A ^a   Hidalgo, Maria A ^a   Hancke, Juan L ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

Author keywords

Aristotelia chilensis; Colon cancer; COX 2; NF B

Indexed keywords

ANTHOCYANIN; CYANIDIN 3 O SAMBUBIOSIDE; CYANIDIN 3 O SAMBUBIOSIDE 5 OMEGA GLUCOSIDE; CYANIDIN 3 OMEGA GLUCOSIDE; CYCLOOXYGENASE 2; DELPHINIDIN 3 O SAMBUBIOSIDE; DELPHINIDIN 3 O SAMBUBIOSIDE 5 OMEGA GLUCOSIDE; DELPHINIDIN 3 OMEGA GLUCOSIDE; DELPHINIDIN 3,5 OMEGA GLUCOSIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C FOS; PROTEIN KINASE B; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARISTOTELIA CHILENSIS; ARTICLE; BERRY; BERRY JUICE; CANCER CELL CULTURE; CELL STRAIN CACO 2; CELL VIABILITY; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FRUIT JUICE; GENE EXPRESSION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 83055173915     PISSN: None     EISSN: 07177917     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Accioly MT, Pacheco P, Maya-Monteiro CM, Carrossini N, Robbs BK, Oliveira SS, Kaufmann C, Morgado-Diaz JA, Bozza PT, Viola JP. 2008. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin E2 synthesis in colon cancer cells. Cancer Res 68: 1732-1740.
2. Antonakopoulos N, Karamanolis DG. 2007. The role of NSAIDs in colon cancer prevention. Hepatogastroenterology 54: 1694-1700.
3. Boivin D, Blanchette M, Barrette S, Moghrabi A, Beliveau R. 2007. Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice. Anticancer Res 27: 937-948.
4. Buzzi N, Colicheo A, Boland R, de Boland AR. 2009. MAP kinases in proliferating human colon cancer Caco-2 cells. Mol Cell Biochem 328: 201-208.
5. Corral RS, Iniguez MA, Duque J, Lopez-Perez R, Fresno M. 2007. Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells. Oncogene 26: 958-969.
6. Cha YI, DuBois RN. 2007. NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med 58: 239-252.
7. Chan AT, Ogino S, Fuchs CS. 2007. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356: 2131-2142.
8. Dianzani C, Brucato L, Gallicchio M, Rosa AC, Collino M, Fantozzi R. 2008. Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression. Br J Pharmacol 153: 1153-1161.
9. Duque J, Diaz-Munoz MD, Fresno M, Iniguez MA. 2006. Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells. Cell Signal 18: 1262-1269.
10. Duque J, Fresno M, Iniguez MA. 2005. Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. J Biol Chem 280: 8686-8693.
11. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. 1994. Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188.
12. Escribano-Bailon MT, Alcalde-Eon C, Munoz O, Rivas-Gonzalo JC, Santos-Buelga C. 2006. Anthocyanins in berries of Maqui (Aristotelia chilensis (Mol.) Stuntz). Phytochem Anal 17: 8-14.
13. Gallicchio M, Rosa AC, Dianzani C, Brucato L, Benetti E, Collino M, Fantozzi R. 2008. Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29). Br J Pharmacol 153: 870-878.
14. Harris RE. 2009. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology 17: 55-67.
15. Harris RE, Beebe-Donk J, Alshafie GA. 2008. Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase2 (COX-2) inhibitors. BMC Cancer 8: 237.
16. Hidalgo MA, Ojeda F, Eyre P, LaBranche TP, Smith C, Hancke JL, Burgos RA. 2004. Plateletactivating factor increases pH(i) in bovine neutrophils through the PI3K-ERK1/2 pathway. Br J Pharmacol 141: 311-321.
17. Hoffmann HJ, Lyman SK, Lu C, Petit MA, Echols H. 1992. Activity of the Hsp70 chaperone complex--DnaK, DnaJ, and GrpE--in initiating phage lambda DNA replication by sequestering and releasing lambda P protein. Proc Natl Acad Sci U S A 89: 12108-12111.
18. Huls G, Koornstra JJ, Kleibeuker JH. 2003. Nonsteroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362: 230-232.
19. Kang NJ, Lee KW, Kwon JY, Hwang MK, Rogozin EA, Heo YS, Bode AM, Lee HJ, Dong Z. 2008. Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogen-activated protein kinase kinase/extracellular signalregulated kinase signaling. Cancer Prev Res (Phila Pa) 1: 522-531.
20. Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL. 2007. Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 46: 108-125.
21. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. 1995. Expression of prostaglandin G/H synthase-1 and2 protein in human colon cancer. Cancer Res 55: 2556-2559.
22. Kim JM, Kim JS, Yoo H, Choung MG, Sung MK. 2008. Effects of black soybean [Glycine max (L.) Merr.] seed coats and its anthocyanidins on colonic inflammation and cell proliferation in vitro and in vivo. J Agric Food Chem 56: 8427-8433.
23. Kok K, Geering B, Vanhaesebroeck B. 2009. Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci 34: 115-127.
24. Kopp E, Ghosh S. 1994. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959.
25. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL, Prescott SM. 1996. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A 93: 4816-4820.
26. Kyriakis JM, Avruch J. 2001. Mammalian Mitogen Activated Protein Kinase Signal Transduction Pathways Activated by Stress and Inflammation. Physiol Rev 81: 807-869.
27. Lala G, Malik M, Zhao C, He J, Kwon Y, Giusti MM, Magnuson BA. 2006. Anthocyanin-rich extracts inhibit multiple biomarkers of colon cancer in rats. Nutr Cancer 54: 84-93.
28. Miranda-Rottmann S, Aspillaga AA, Perez DD, Vasquez L, Martinez AL, Leighton F. 2002. Juice and phenolic fractions of the berry Aristotelia chilensis inhibit LDL oxidation in vitro and protect human endothelial cells against oxidative stress. J Agric Food Chem 50: 7542-7547.
29. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
30. Munoz-Espada AC, Watkins BA. 2006. Cyanidin attenuates PGE2 production and cyclooxygenase-2 expression in LNCaP human prostate cancer cells. J Nutr Biochem 17: 589-596.
31. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T. 1995. Expression of cyclooxygenase-1 and2 in human colorectal cancer. Cancer Res 55: 3785-3789.
32. Saunders MA, Sansores-Garcia L, Gilroy DW, Wu KK. 2001. Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts. J Biol Chem 276: 18897-18904.
33. Seeram NP, Momin RA, Nair MG, Bourquin LD. 2001. Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine 8: 362-369.
34. Seeram NP. 2008. Berry fruits: compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease. J Agric Food Chem 56: 627-629.
35. Shtivelband MI, Juneja HS, Lee S, Wu KK. 2003. Aspirin and salicylate inhibit colon cancer medium and VEGF-induced endothelial tube formation: correlation with suppression of cyclooxygenase-2 expression. J Thromb Haemost 1: 2225-2233.
36. Tsoyi K, Park HB, Kim YM, Chung JI, Shin SC, Lee WS, Seo HG, Lee JH, Chang KC, Kim HJ. 2008. Anthocyanins from black soybean seed coats inhibit UVB-induced inflammatory cylooxygenase-2 gene expression and PGE2 production through regulation of the nuclear factor-kappaB and phosphatidylinositol 3 kinase/Akt pathway. J Agric Food Chem 56: 8969-8974.
37. Wang Q, Xia M, Liu C, Guo H, Ye Q, Hu Y, Zhang Y, Hou M, Zhu H, Ma J, Ling W. 2008. Cyanidin-3-O-beta-glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor alpha activation in THP-1 macrophages. Life Sci 83: 176-184.
38. Weaver SA, Russo MP, Wright KL, Kolios G, Jobin C, Robertson DA, Ward SG. 2001. Regulatory role of phosphatidylinositol 3-kinase on TNF- alpha-induced cyclooxygenase 2 expression in colonic epithelial cells. Gastroenterology 120: 1117-1127.
39. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. 2006. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 54: 4069-4075.
40. Yin MJ, Yamamoto Y, Gaynor RB. 1998. The anti inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396: 77-80.